|
|||
|
Multiple Sclerosis Information
Search
This Month
Favorite Links
Month Archive
|
« Previous
Saturday, July 25
Natalizumab associated with pro-inflammatory T cells
by
All About MS
on Sat 25 Jul 2009 12:00 AM CST
Natalizumab is an antibody directed against integrin alpha4 that reduces disease activity in patients with multiple sclerosis (MS) by blocking migration of T and B cells into the Central Nervouse System (CNS). The goal of this study was more »
Friday, July 24
Swine Flu Vaccination 2 of 2
by
All About MS
on Fri 24 Jul 2009 11:03 AM CST
A flurry of innovative vaccine trials is in the offing as governments and regulatory agencies prepare for the probable launch of mass swine flu vaccination programs in the fall.
The results of the trials could determine whether people more »
Tuesday, July 14
Smoking May Equal Rapid Progression of MS
by
All About MS
on Tue 14 Jul 2009 11:53 AM CST
Patients with multiple sclerosis (MS) who smoke appear to experience a more rapid progression of their disease, according to a study published in the July issue of Archives of more »
Sunday, July 12
Kineta Acquires Novel Drug Candidates from Airmid
by
All About MS
on Sun 12 Jul 2009 11:38 AM CST
Kineta, Inc. of Seattle and Airmid Incorporated of Redwood City, CA jointly announce an agreement in which a Kineta subsidiary has acquired exclusive commercial rights to a portfolio of novel therapeutic compounds from Airmid. The array of compounds holds extraordinary potential more »
Friday, July 10
phase III trial of Mylinax (oral cladribine)
by
All About MS
on Fri 10 Jul 2009 04:30 PM CST
Over the two-year period of the study, 80% of the low dose regimen Cladribine arm and 79% of the high-dose regimen arm experienced no clinical relapse, compared with 61% of the more »
Drug Trial - Female Stress Urinary Incontinence
by
All About MS
on Fri 10 Jul 2009 04:18 PM CST
Over 11 million women in the United States suffer from stress urinary incontinence (SUI), the involuntary leakage of urine during routine physical activities such as laughing, coughing, exercising, or sneezing. SUI affects women more »
Monday, July 6
U.S. Study Will Test Vitamin D, Fish Oil
by
All About MS
on Mon 06 Jul 2009 12:00 AM CST
Two of the most popular and promising dietary supplements -- vitamin D and fish oil -- will be tested in a large, government-sponsored study to see whether either nutrient can lower a healthy person's risk of getting cancer more »
Sunday, July 5
Oral Laquinimod Phase III MS Clinical Trial
by
All About MS
on Sun 05 Jul 2009 11:02 AM CST
Teva Pharmaceutical Industries Ltd. and Active Biotech today announced completion of patient enrollment for the second pivotal Phase III clinical trial, BRAVO, evaluating the novel, oral once-daily immunomodulating more »
Saturday, July 4
New Theory for Why Repair of the Brain’s Wiring Fails
by
All About MS
on Sat 04 Jul 2009 12:00 AM CST
Scientists have uncovered new evidence suggesting that damage to nerve cells in people with multiple sclerosis (MS) accumulates because the body’s natural mechanism for repairing the nerve coating more »
Study - Spasticity
by
All About MS
on Sat 04 Jul 2009 12:00 AM CST
This research study will evaluate a treatment for moderate to severe spasticity associated with MS. All patients must have been on baclofen for at least four weeks prior to first visit. This study requires more »
Friday, July 3
Study - Restless Legs
by
All About MS
on Fri 03 Jul 2009 10:53 AM CST
Discomfort or pain in your legs which worsens at night or when resting
A strong urge to move your legs for relief
Itching, pulling, creepy-crawly, tugging, or gnawing more »
Monday, June 29
Autoinjection Device Appears subcutaneous injections of interferon beta (IFNB)-1a
by
All About MS
on Mon 29 Jun 2009 04:55 PM CST
A new electronic, multidose, autoinjection device improves subcutaneous delivery of interferon beta (IFNB)-1a in patients with relapsing multiple sclerosis (MS), according to a study presented here at the 19th Meeting of the European more »
Sunday, June 28
Cognitive function Improved by disease-modifying therapies
by
All About MS
on Sun 28 Jun 2009 10:30 AM CST
Patients with relapsing-remitting multiple sclerosis (RRMS) who receive glatiramer acetate (GA) or interferon (IFN) beta show a reduction in cognitive impairment and relative stability of cognitive and affective variables at 2 years, according to the results of an observational study presented more »
Friday, June 26
Richer Source for Stem Cells = Placentas?
by
All About MS
on Fri 26 Jun 2009 11:24 AM CST
The human placenta could be an important source of stem cells for curing leukemia, sickle cell disease and other blood-related disorders, a new study reveals. These stem cells appear to have distinct advantages over the techniques currently used to fight such diseases, and they more »
Sunday, June 21
Clinical Study – Volunteers Needed 2
by
All About MS
on Sun 21 Jun 2009 01:00 AM CST
This is an early phase study designed to test the safety of a compound. This is one of the steps necessary before conducting a large clinical trial to determine if the agent ONO-4641 is effective in MS.
Main Eligibility R more »
|
||
